GW Pharmaceuticals

Latest articles

5d
FOX Business
Why I Will Never Invest in Marijuana Stocksand I wouldn't argue with that. However, if that's why you're investing in the
FOX Business / Posted 5 days ago
and I wouldn't argue with that. However, if that's why you're investing in the space then why not look at companies like GW Pharmaceuticals(NASDAQ: GWPH), Corbus Pharmaceuticals Holdings(NASDAQ: CRBP), and Insys Therapeutics(NASDAQ: INSY). These... Read more
5d
FOX Business
Why I Will Never Invest in Marijuana Stocksand I wouldn't argue with that. However, if that's why you're investing in the
FOX Business / Posted 5 days ago
and I wouldn't argue with that. However, if that's why you're investing in the space then why not look at companies like GW Pharmaceuticals(NASDAQ: GWPH), Corbus Pharmaceuticals Holdings(NASDAQ: CRBP), and Insys Therapeutics(NASDAQ: INSY). These... Read more
6d
International Business Times
Inside the Red Tape Initiative – the cross-party search for 'hidden Brexit nuggets' We will go with the process as it evolves," Tyrone said. As for funding, the g
International Business Times / Posted 6 days ago
We will go with the process as it evolves," Tyrone said. As for funding, the group has a "handful of donors", including GW Pharmaceuticals chairman Geoffrey Guy, but Tyrone denied any connection or money from Tony Pidgley's Berkeley Homes after... Read more
7d
FOX Business
Forget GW PharmaceuticalsYes, GW Pharmaceuticals(NASDAQ: GWPH) is the biggest marijuana-focused biotech
FOX Business / Posted 7 days ago
Yes, GW Pharmaceuticals(NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in the near future in treating children with rare... Read more
7d
FOX Business
Forget GW PharmaceuticalsYes, GW Pharmaceuticals(NASDAQ: GWPH) is the biggest marijuana-focused biotech
FOX Business / Posted 7 days ago
Yes, GW Pharmaceuticals(NASDAQ: GWPH) is the biggest marijuana-focused biotech stock on the market. The company's promising cannabinoid Epidiolex could very well become a blockbuster success story in the near future in treating children with rare... Read more
13d
Chicago Tribune
From dog treats to massage oils, hemp sales soar, and medical pot industry wants inseizures in children with rare forms of epilepsy, prompting the FDA to allow sp
Chicago Tribune / Posted 13 days ago
seizures in children with rare forms of epilepsy, prompting the FDA to allow special access to the drug for that purpose. GW Pharmaceuticals, which makes a CBD extract called Epidiolex, plans to file for FDA approval of it this year. In addition,... Read more
17d
FOX Business
Wow! 92% of Patients Prefer Medical Marijuana to Opioids, New Survey Showsgiven how encouraging cannabinoid- and CB receptor-based research has been for
FOX Business / Posted 17 days ago
given how encouraging cannabinoid- and CB receptor-based research has been for select drug developers. For example, GW Pharmaceuticals(NASDAQ: GWPH), the kingpin of all marijuana stocks based on market cap, has developed an oral... Read more
17d
FOX Business
Wow! 92% of Patients Prefer Medical Marijuana to Opioids, New Survey Showsgiven how encouraging cannabinoid- and CB receptor-based research has been for
FOX Business / Posted 17 days ago
given how encouraging cannabinoid- and CB receptor-based research has been for select drug developers. For example, GW Pharmaceuticals(NASDAQ: GWPH), the kingpin of all marijuana stocks based on market cap, has developed an oral... Read more
17d
FOX Business
The Chance to Sidestep a Marijuana Medicine Sent This Stock Soaring 14% in Junesyndrome. If its phase 3 trials in Dravet syndrome pan out, ZX008 could someda
FOX Business / Posted 17 days ago
syndrome. If its phase 3 trials in Dravet syndrome pan out, ZX008 could someday be pitted head-to-head against GW Pharmaceuticals' (NASDAQ: GWPH) marijuana-derived drug Epidiolex. Based on small early-stage studies, ZX008 could stand a... Read more
17d
FOX Business
The Chance to Sidestep a Marijuana Medicine Sent This Stock Soaring 14% in Junesyndrome. If its phase 3 trials in Dravet syndrome pan out, ZX008 could someda
FOX Business / Posted 17 days ago
syndrome. If its phase 3 trials in Dravet syndrome pan out, ZX008 could someday be pitted head-to-head against GW Pharmaceuticals' (NASDAQ: GWPH) marijuana-derived drug Epidiolex. Continue Reading Below Based on small early-stage... Read more
27d
EDP24 - Eastern Daily Press
Mystery of Norfolk smell deepens as British Sugar investigatesbecause of a deal struck in October last year between Cornerways, owner of Brit
EDP24 - Eastern Daily Press / Posted 27 days ago
because of a deal struck in October last year between Cornerways, owner of British Sugar, and the British drugs company, GW Pharmaceuticals. This deal meant that the Wissington plant would cease tomato production and instead turn to cultivating... Read more
27d
Norwich Evening News 24
Mystery of Norfolk smell deepens as British Sugar investigatesbecause of a deal struck in October last year between Cornerways, owner of Brit
Norwich Evening News 24 / Posted 27 days ago
because of a deal struck in October last year between Cornerways, owner of British Sugar, and the British drugs company, GW Pharmaceuticals. This deal meant that the Wissington plant would cease tomato production and instead turn to cultivating... Read more
30d
FOX Business
3 Marijuana Stocks to Buy If You've Never Bought a Marijuana Stockin the growth of the marijuana industry, but with more stability than you would
FOX Business / Posted 30 days ago
in the growth of the marijuana industry, but with more stability than you would get buying a micro-cap marijuana stock.GW Pharmaceuticals GW Pharmaceuticals is, for now at least, the largest biotech specializing in the development of... Read more
30d
FOX Business
3 Marijuana Stocks to Buy If You've Never Bought a Marijuana Stockmarijuana industry, but with more stability than you would get buying a micro-c
FOX Business / Posted 30 days ago
marijuana industry, but with more stability than you would get buying a micro-cap marijuana stock. Continue Reading Below GW Pharmaceuticals is, for now at least, the largest biotech specializing in the development of marijuana-based drugs. The... Read more

In this news